SLC16A9: Monocarboxylate Transporter 9 (MCT9)

Solute Carrier Family 16 Member 9 – Genetic Variants, Expression, and Disease Associations

Gene Information Card

Symbol SLC16A9
Full Name Solute Carrier Family 16 Member 9
Gene Type Protein coding
Chromosomal Location 10q21.2
NCBI Gene ID 220963 ncbi.nlm.nih.gov/gene/220963
Ensembl ID ENSG00000165496
UniProt ID Q7Z7H8
OMIM ID 611645
HGNC ID 23023
Aliases MCT9, MCT-9, monocarboxylate transporter 9

Description

SLC16A9 encodes monocarboxylate transporter 9 (MCT9), a member of the solute carrier family 16. MCT9 is a proton-coupled transporter involved in the cellular uptake of monocarboxylates such as lactate, pyruvate, and ketone bodies. It also mediates carnitine transport. Genetic variants in SLC16A9 are associated with altered serum uric acid levels and renal hypouricemia. The gene is expressed in kidney, liver, and brain, and its dysregulation has been implicated in metabolic disorders and cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Renal hypouricemia Loss-of-function variants impair urate transport, leading to low serum uric acid and increased risk of exercise-induced acute kidney injury. ClinVar, OMIM #611645
Hyperuricemia / gout Common variants (e.g., rs2242206) are associated with elevated serum uric acid levels and gout risk. GWAS, NCBI dbSNP
Carnitine deficiency Impaired carnitine transport due to SLC16A9 dysfunction may contribute to systemic carnitine deficiency. UniProt annotation

Expression Profile

Tissue Expression
Tissue nTPM level
Kidney 12.5 High
Liver 8.3 Medium
Brain 6.1 Medium
Heart 4.2 Low
Skeletal muscle 2.8 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.2 High expression in transfected cells
HepG2 9.7 Moderate endogenous expression
SH-SY5Y 5.4 Low endogenous expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.124G>A (p.Gly42Arg) Missense <0.01% Reduced urate transport activity; associated with renal hypouricemia
c.487C>T (p.Arg163Trp) Missense <0.01% Loss of function; reported in hypouricemia patients
rs2242206 (intronic) SNP ~30% (Asian) Associated with increased serum uric acid levels
Mutation functional classification

Loss of Function (LOF)

Missense variants (e.g., p.Gly42Arg, p.Arg163Trp) impair monocarboxylate/urate transport, leading to renal hypouricemia.

Gain of Function (GOF)

No confirmed gain-of-function variants reported.

Dominant Negative (DN)

Not described for SLC16A9.

Pathways

Transport of monocarboxylates (Reactome: R-HSA-425366)
Carnitine shuttle (Reactome: R-HSA-1483196)
SLC-mediated transmembrane transport (Reactome: R-HSA-425407)

Protein Summary

MCT9 (UniProt Q7Z7H8) is a 12-transmembrane domain protein of 487 amino acids. It functions as a proton-coupled monocarboxylate transporter, with substrate preference for lactate, pyruvate, and carnitine. The protein is localized to the plasma membrane and is highly expressed in kidney proximal tubules, where it mediates urate reabsorption. Structural modeling suggests a conserved substrate-binding pocket. Post-translational modifications include N-glycosylation at Asn57.

Related Products

Product name Cat.No. Species Gene ID
SLC16A9 Knockout HEK293 Cell Line EDJ-KQ8785 Human 220963 Details Get a Quote
SLC16A9 Knockout HCT 116 Cell Line EDJ-KQ35061 Human 220963 Details Get a Quote
SLC16A9 Knockout HeLa Cell Line EDJ-KQ59146 Human 220963 Details Get a Quote
SLC16A9 Knockout A-549 Cell Line EDJ-KQ67620 Human 220963 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: